Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

CL vs PG: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PG Captures Overall Composite Edge (33.6 SELL vs 32.6 SELL), While CL Leads 3–2 on Growth & Valuation Pillars

PG Overall Winner 6-Pillar Tally: CL 3 – 2 PG (1 Tie) Matrix Metrics: CL 2 – 6 PG

As of Nov 20, 2026, Procter & Gamble Company (PG) captures the overall head-to-head institutional edge over Colgate-Palmolive Company (CL) on higher Unified Composite conviction (33.6/100 SELL vs. 32.6/100 SELL) after splitting the core matrix 6–2 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CL wins 3–2 across the 6-pillar growth and valuation breakdown. CL trades at $98.71 (24.1x Forward P/E, 20.7% operating margin) versus PG at $169.37 (24.0x Forward P/E, 24.9% operating margin).

  • Growth vs. Quality Trade-Off: PG earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. CL 32.6/100 SELL) and 0.02β · 21% Vol risk profile, whereas CL leads top-line expansion (+4.6% YoY revenue growth, 1.81x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates.
  • Defensive Composite Rating Caution: Although PG compares more favorably head-to-head, both CL (32.6/100 SELL) and PG (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CL vs PG
CL NYSE
Colgate-Palmolive Company
Perfumes, Cosmetics & Other Toilet Preparations
$98.71
+1.89% 1D
Market Cap $77.0B
TTM Revenue $21.3B
Forward P/E 24.1x
Beta / 30D Vol -0.05β · 28% Vol
Unified Composite Score
32.6 / 100 SELL
Tech 28.0 Fund 40.0 Flow 56.0 Mom 25.9
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 58
RSI-14: 57.6 · SMA20: $96.96 · SMA50: $92.06
PG NYSE Head-to-Head Winner
Procter & Gamble Company
Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
$169.37
+0.91% 1D
Market Cap $389.0B
TTM Revenue $87.9B
Forward P/E 24.0x
Beta / 30D Vol 0.02β · 21% Vol
Unified Composite Score
33.6 / 100 SELL
Tech 19.0 Fund 38.0 Flow 56.0 Mom 40.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.7% over 20 days), RSI 61
RSI-14: 61.0 · SMA20: $165.99 · SMA50: $156.84

6-Pillar Scorecard Institutional Category Breakdown (CL 3 – 2 PG)

Columns: Metric · CL · PG
1. Valuation Multiples CL
Forward P/E 24.1x 24.0x
Trailing P/E 38.4x 25.3x
PEG Ratio 1.81x 4.38x
EV / Revenue 3.9x 4.7x
2. Growth & Scale CL
Revenue Growth (YoY) +4.6% +4.0%
Earnings Growth (YoY) +3.3% +0.8%
TTM Revenue (USD) $21.3B $87.9B
Market Cap $77.0B $389.0B
3. Profitability & Quality PG
Gross Margin 60.6% 50.6%
Operating Margin 20.7% 24.9%
Net Profit Margin 9.7% 18.2%
Return on Equity (ROE) 231.7% 29.6%
4. Balance Sheet & Cash Flow PG
Cash Generation (TTM) $3.79B $15.3B
Cash Flow Margin 17.8% 17.4%
Net Cash / Leverage $6.19B Net Debt (26.79x D/E) $23.6B Net Debt (0.71x D/E)
Dividend Yield 2.12% 2.52%
5. Options & Positioning Tie
Options Structure Phase SURGE SURGE
Current IV / %ile 29.6% (9th %ile) 15.0% (12th %ile)
Put/Call OI Skew 0.50x (Call-Skewed) 0.59x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Markup ACCUMULATION · Markup
6. R&D & Supply-Chain Moat CL
OpEx & R&D Intensity 39.9% of Rev ($8.49B) 25.7% of Rev ($22.6B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat High-Margin Pricing Power Moat Scale & Operating Efficiency Moat
Supply-Chain Role Household & Personal Products Operator Household & Personal Products Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CL (2) vs PG (6)
Institutional Metric CL PG Criterion Row Edge
Market Capitalization
Scale
$77.0B $389.0B Larger Scale PG
Trailing P/E Ratio
Valuation
38.4x 25.3x Lower Multiple PG
Forward P/E Ratio
Valuation
24.1x 24.0x Lower Multiple Tie
Revenue Growth (YoY)
Growth
+4.6% +4.0% Higher Growth CL
Operating Margin (TTM)
Profitability
20.7% 24.9% Higher Margin PG
Net Profit Margin
Profitability
9.7% 18.2% Higher Margin PG
Return on Equity (ROE)
Capital Efficiency
231.7% 29.6% Higher ROE CL
52-Week Range Position
Momentum
88% ($76–$102) 88% ($138–$174) Stronger Trend Tie
Beta / 30D Volatility
Risk Regime
-0.05β · 28% Vol 0.02β · 21% Vol Lower Realized Risk PG
Unified Institutional Score
Composite Signal
32.6 / 100 (SELL) 33.6 / 100 (SELL) Higher Composite PG
Trailing 12M Revenue (USD)
Operating Scale
$21.3B $87.9B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
60.6% 50.6% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.81x PEG · 3.9x EV/Rev 4.38x PEG · 4.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$3.79B ($6.19B Net Debt (26.79x D/E)) $15.3B ($23.6B Net Debt (0.71x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PG +0.92 pp
CL: +1.36% · PG: +2.28%
3M Horizon PG +8.87 pp
CL: +6.66% · PG: +15.53%
6M Horizon PG +8.32 pp
CL: +8.94% · PG: +17.26%
1Y Horizon CL +10.56 pp
CL: +25.79% · PG: +15.23%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CL Revenue PG Revenue CL Op. Margin PG Op. Margin Margin Leader
FY2019 $15.7B $67.7B 22.6% 8.1% CL
FY2020 $16.5B $71.0B 23.6% 22.1% CL
FY2021 $17.4B $76.1B 19.1% 23.6% PG
FY2022 $18.0B $80.2B 16.1% 22.2% PG
FY2023 $19.5B $82.0B 20.5% 22.1% PG
FY2024 $20.1B $84.0B 21.2% 22.1% PG
FY2025 $20.4B $84.3B 16.2% 24.3% PG
FY2026 N/A $87.0B N/A 22.7% PG

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CL SURGE
5d in phase · OBV NEUTRAL
Current IV 29.6%
IV Percentile 9th %ile
Put/Call OI Skew 0.50x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CL Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
PG SURGE
5d in phase · OBV ACCUMULATION
Current IV 15.0%
IV Percentile 12th %ile
Put/Call OI Skew 0.59x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow ACCUMULATION
Exact PG Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $100.99 · IV 25.0%

CL vs. PG: Simulated 5-Day Option Payoffs & Capital Efficiency

Compare 100 shares of CL ($10,099) vs. PG ($17,302) against risk-defined 5-day vertical and put-wall option structures.

CL Spot $100.99 · IV 25.0%
CL Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $100 / $105 Bull Call Spread

Buy 1x $100C · Sell 1x $105C · 31d

Net Entry $220 Debit
T+5d @ +5% Move +$132 (+60%)
Max Risk / Buffer $220 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $95 / $90 Bull Put Spread

Sell 1x $95P · Buy 1x $90P · 31d

Net Entry $48 Credit
Max Credit / Yield +$48 (+10.6% RoM)
Max Risk / Buffer -6.4% Cushion ($452 Mgn)
5d Edge & Liquidity 82% PoP · Liq A
Simulate 5-Day Payoff →
PG Spot $173.02 · IV 22.7%
PG Options Simulator →
5-DAY BULLISH SWING Liq A

Dec 18 $170 / $180 Bull Call Spread

Buy 1x $170C · Sell 1x $180C · 31d

Net Entry $456 Debit
T+5d @ +5% Move +$306 (+67%)
Max Risk / Buffer $456 Capped
5d Edge & Liquidity 0.9x R:R · Liq A
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq A

Dec 18 $165 / $155 Bull Put Spread

Sell 1x $165P · Buy 1x $155P · 31d

Net Entry $114 Credit
Max Credit / Yield +$114 (+12.9% RoM)
Max Risk / Buffer -5.3% Cushion ($886 Mgn)
5d Edge & Liquidity 78% PoP · Liq A
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CL Moat Profile High-Margin Pricing Power Moat
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $77.0B market capitalization and 20.7% operating margin.
OpEx & R&D Reinvestment 39.9% of Rev ($8.49B)
90D Engineering Disclosures 0 Published
PG Moat Profile Scale & Operating Efficiency Moat
Household & Personal Products Operator
Competes within the Household & Personal Products value chain with $389.0B market capitalization and 24.9% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($22.6B)
90D Engineering Disclosures 0 Published

Investor FAQ CL vs PG Key Questions & Quantitative Answers

As of Nov 20, 2026, Procter & Gamble Company (PG) captures the overall head-to-head institutional edge over Colgate-Palmolive Company (CL) on higher Unified Composite conviction (33.6/100 SELL vs. 32.6/100 SELL) after splitting the core matrix 6–2 (led by Profitability & Quality, Balance Sheet & Cash Flow), while CL wins 3–2 across the 6-pillar growth and valuation breakdown. CL trades at $98.71 (24.1x Forward P/E, 20.7% operating margin) versus PG at $169.37 (24.0x Forward P/E, 24.9% operating margin). Growth vs. Quality Trade-Off: PG earns the overall head-to-head edge with a stronger Unified Composite Score (33.6/100 SELL vs. CL 32.6/100 SELL) and 0.02β · 21% Vol risk profile, whereas CL leads top-line expansion (+4.6% YoY revenue growth, 1.81x PEG, and 3 of 6 institutional pillars) for higher-beta growth mandates. Defensive Composite Rating Caution: Although PG compares more favorably head-to-head, both CL (32.6/100 SELL) and PG (33.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

CL leads the Growth & Scale pillar: CL posts +4.6% YoY revenue growth and +3.3% YoY earnings growth on $21.3B TTM revenue (60.6% gross margin, 20.7% operating margin), compared with PG at +4.0% YoY revenue growth and +0.8% YoY earnings growth on $87.9B TTM revenue (50.6% gross margin, 24.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CL cumulative revenue shifted +29.9% while PG shifted +28.6%. In operating R&D and SG&A reinvestment, CL deploys 39.9% of Rev ($8.49B) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($22.6B) (0 disclosures) for PG.

CL screens cheaper on headline valuation multiples. CL trades at 24.1x Forward P/E, 38.4x Trailing P/E, 1.81x PEG, and 3.9x EV/Revenue (17.8% FCF margin), whereas PG trades at 24.0x Forward P/E, 25.3x Trailing P/E, 4.38x PEG, and 4.7x EV/Revenue (17.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CL (231.7% ROE) versus PG (29.6% ROE) capital efficiency.

In options market volatility and institutional positioning, CL carries 29.6% implied volatility (9th %ile, Compressed (<25th %ile)), a 0.50x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.05β · 28% Vol realized risk). By comparison, PG carries 15.0% implied volatility (12th %ile, Compressed (<25th %ile)), a 0.59x (Call-Skewed) Put/Call open-interest ratio, ACCUMULATION on-balance volume, and sits in a SURGE options structure phase (0.02β · 21% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.